A Phase 2/3, Two-Part, Open-Label, Dose-Escalation, Age De-escalation and Randomized, Observer-Blind, Placebo-Controlled, Expansion Study to Evaluate the Safety, Tolerability, Reactogenicity, and Effe
Research Grant
Administered By
Surgery, Surgical Sciences
Awarded By
Moderna Therapeutics, Inc.
Start Date
June 1, 2021
End Date
May 31, 2024
Administered By
Surgery, Surgical Sciences
Awarded By
Moderna Therapeutics, Inc.
Start Date
June 1, 2021
End Date
May 31, 2024